Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease

Autor: Tracy Pellatt-Higgins, Jon Deeks, Alice J Sitch, Frances S Morris, Maarten W. Taal, Edmund J. Lamb, Ryan S Ottridge, Claire C. Sharpe, Fiona C Loud, Paul Cockwell, Kamlesh Khunti, Gillian Eaglestone, Paul E. Stevens, Philip A. Kalra, Elizabeth Brettell, Jonathan Barratt, Andrew Sutton, R Neil Dalton, Ceri Rowe
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Nephrology
Male
Modification of Diet in Renal Disease Study
Epidemiology
kidney disease
030232 urology & nephrology
urologic and male genital diseases
chemistry.chemical_compound
0302 clinical medicine
Biological variation
cystatin C
reproductive and urinary physiology
Aged
80 and over

glomerular filtration rate
biology
creatinine
Kidney disease
Middle Aged
Reference Standards
Chronic Kidney disease
female genital diseases and pregnancy complications
Female
medicine.drug
Modification of Diet in Renal Disease score
Glomerular Filtration Rate
medicine.medical_specialty
Iohexol
Urology
Renal function
03 medical and health sciences
Internal medicine
medicine
Creatinin
Humans
Cystatin C
Renal Insufficiency
Chronic

Aged
biological variation
Creatinine
business.industry
urogenital system
Chronic Kidney Disease Epidemiology Collaboration
medicine.disease
Confidence interval
030104 developmental biology
chemistry
biology.protein
iohexol
business
Zdroj: Rowe, C, Sitch, A J, Barratt, J, Brettell, E A, Cockwell, P, Dalton, R N, Deeks, J J, Eaglestone, G, Pellatt-higgins, T, Kalra, P A, Khunti, K, Loud, F C, Morris, F S, Ottridge, R S, Stevens, P E, Sharpe, C C, Sutton, A J, Taal, M W & Lamb, E J 2019, ' Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease ', Kidney International, vol. 96, no. 2, pp. 429-435 . https://doi.org/10.1016/j.kint.2019.02.021
ISSN: 0085-2538
1523-1755
Popis: When assessing changes in glomerular filtration rate (GFR) it is important to differentiate pathological change from intrinsic biological and analytical variation. GFR is measured using complex reference methods (e.g., iohexol clearance). In clinical practice measurement of creatinine and cystatin C are used in the Modification of Diet in Renal Disease [MDRD] or Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI] equations to provide estimated GFR. Here we studied the biological variability of measured and estimated GFR in twenty nephrology outpatients (10 male, 10 female; median age 71, range 50-80 years) with moderate CKD (GFR 30-59 ml/min per 1.73 m2). Patients underwent weekly GFR measurement by iohexol clearance over four consecutive weeks. Simultaneously, GFR was estimated using the MDRD, CKD-EPIcreatinine, CKD-EPIcystatinC and CKD-EPIcreatinine+cystatinC equations. Within-subject biological variation expressed as a percentage [95% confidence interval] for the MDRD (5.0% [4.3-6.1]), CKD-EPIcreatinine (5.3% [4.5-6.4]), CKD-EPIcystatinC (5.3% [4.5-6.5]), and CKD-EPIcreatinine+cystatinC (5.0% [4.3-6.2]) equations were broadly equivalent. The within-subject biological variation for MDRD and CKD- EPIcreatinine+cystatinC estimated GFR were each significantly lower than that of the measured GFR (6.7% [5.6-8.2]). Reference change values, the point at which a true change in a biomarker in an individual can be inferred to have occurred with 95% probability were calculated. By the MDRD equation, positive and negative reference change values were 15.1% and 13.1% respectively. If an individual's baseline MDRD estimated GFR (ml/min per 1.73 m2) was 59, significant increases or decreases would be to values over 68 or under 51 respectively. Within-subject variability of estimated GFR was lower than measured GFR. Reference change values can be used to understand GFR changes in clinical practice. Thus, estimates of GFR are at least as reliable as measured GFR for monitoring patients over time.
Databáze: OpenAIRE